CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit

Statin Drug Intolerance

Esperion Therapeutics

Esperion Therapeutics Presents Promising Test Results On Cholesterol Drug

The pharma startup Esperion Therapeutics Inc. Monday announced full results of a Phase 2 clincal study of its lead drug candidate, called ETC-1002. The drug is intended to reduce high cholesterol levels in patients with a history of intolerance to today’s cholesterol-lowering statin drugs.

WWJ Newsradio 950–11/18/2013

Follow

Get every new post delivered to your Inbox.

Join 1,916 other followers